Bench International and Deloitte Launch the Bench and Deloitte Life Sciences Tech Innovation Award to Celebrate Outstanding Women in Life Sciences

San Diego, CA, February 14, 2024 — Bench International, a global leader in life sciences executive recruitment, collaborates with Deloitte Consulting LLP* to launch the inaugural “Bench and Deloitte Life Sciences Tech Innovation Award.” This prestigious accolade recognizes outstanding women in life sciences and health care, highlighting their exceptional contributions to these fields.

The award aligns with Bench International’s commitment to championing female leaders, showcased by its Bank of Women® initiative, empowering over 1,500 executive women. Dedicated to diversity, equity, and inclusion, the award provides a platform to honor impactful female leaders, aligning with Deloitte’s vision as a purpose-driven enterprise.

“At Deloitte, we believe in the power of a purpose-driven enterprise to make a difference and drive meaningful change,” said Glenn Snyder, Principal, Deloitte Consulting LLP. “Our collaboration on the ‘Bench and Deloitte Life Sciences Tech Innovation Award’ aligns with our vision of fostering diversity, equity, and inclusion in life sciences and health care.”

“We are thrilled to collaborate with Deloitte on this initiative that celebrates the achievements of women who have significantly shaped the life sciences and health care sectors,” said DeeDee DeMan, Chairman and CEO of Bench International. “Through the ‘Bench and Deloitte Life Sciences Tech Innovation Award,’ we aim to not only acknowledge the outstanding contributions of these women but also inspire future generations of women leaders in the industry.”

Nominations have undergone meticulous review by distinguished panelists. The finalists have been selected, and online public voting is now open. Click here to cast your vote by 11:59 PM PT, March 5, 2024.

The celebration culminates on March 14, 2024, at the ‘Bench and Deloitte Life Sciences Tech Innovation Award’ ceremony, a highlight of the LAMedTechWeek Mixer held at BioscienceLA. Industry leaders, panelists, and finalists are cordially invited to partake in this occasion. “As a catalyst for innovation, BioscienceLA seeks to enable diversity, amplify science, and accelerate collaboration,” said David J. Whelan, BioscienceLA CEO. “This award is perfectly aligned with the work that BioscienceLA is doing and the community we are building.”